Zobrazeno 1 - 10
of 1 960
pro vyhledávání: '"proteïnes"'
Publikováno v:
In Médecine des maladies métaboliques December 2024 18(8):674-679
Autor:
Fafournoux, Pierre
Publikováno v:
In Médecine des maladies métaboliques December 2024 18(8):664-673
Autor:
Gaudichon, Claire, Benhaddou, Soukaïna
Publikováno v:
In Médecine des maladies métaboliques December 2024 18(8):648-655
Publikováno v:
In Médecine des maladies métaboliques December 2024 18(8):680-687
Autor:
Bompart, Catherine, Gueugneau, Marine
Publikováno v:
In Médecine des maladies métaboliques December 2024 18(8):656-663
Publikováno v:
Oncotarget. 14:503-513
The signaling pathways displayed by cancer cells are often composed by the same components than the physiological ones, yet the overall result is a pathological deregulation. The non-receptor protein tyrosine kinase Src is a good example. Src is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe2c91fd5d1319306c7edd85d8759a8
https://doi.org/10.18632/oncotarget.28434
https://doi.org/10.18632/oncotarget.28434
Autor:
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean‐Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke, Srdan Verstovsek
Publikováno v:
Mesa, R A, Hudgens, S, Floden, L, Harrison, C N, Palmer, J, Gupta, V, McLornan, D P, McMullin, M F, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, M L, Mead, A J, Ross, D M, Oh, S T, Perkins, A, Leahy, M F, Deheshi, S, Donahue, R, Klencke, B J & Verstovsek, S 2023, ' Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies ', Cancer Medicine . https://doi.org/10.1002/cam4.5799
Scientia
Scientia
Momelotinib; Myelofibrosis; Patient-reported outcomes Momelotinib; Mielofibrosi; Resultats informats pel pacient Momelotinib; Mielofibrosis; Resultados informados por el paciente Background Myelofibrosis (MF)-associated constitutional symptoms can se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfbb9cc40d930868fce1d2a253b5f47
https://doi.org/10.1002/cam4.5799
https://doi.org/10.1002/cam4.5799
Autor:
Laura Rey-Barroso, Mónica Roldán, Francisco J Burgos-Fernández, Ignacio Isola, Anna Ruiz Llobet, Susanna Gassiot, Edurne Sarrate, Meritxell Vilaseca
Publikováno v:
Microscopy and Microanalysis. 29:777-785
In hereditary spherocytosis (HS), genetic mutations in the cell membrane and cytoskeleton proteins cause structural defects in red blood cells (RBCs). As a result, cells are rigid and misshapen, usually with a characteristic spherical form (spherocyt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79daf7aded757a85f893dd988f709c35
https://doi.org/10.1093/micmic/ozac055
https://doi.org/10.1093/micmic/ozac055
Autor:
Ramón Diez-Feijóo, Concepción Fernández-Rodríguez, Marta Lafuente, Nieves García-Gisbert, Ana Ferrer, Luis Colomo, Marta Salido, Antonio Salar
Publikováno v:
Blood Advances. 7:162-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5c5e9971b9fd4946a0ba0aee8ef1d5
https://doi.org/10.1182/bloodadvances.2022008393
https://doi.org/10.1182/bloodadvances.2022008393
Publikováno v:
Free Radical Biology and Medicine. 192:63-76
Selenophosphate synthetases use selenium and ATP to synthesize selenophosphate. This is required for biological utilization of selenium, most notably for the synthesis of the non-canonical amino acid selenocysteine (Sec). Therefore, selenophosphate s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7edbeafface171f501df6c139bded89d
https://doi.org/10.1016/j.freeradbiomed.2022.09.007
https://doi.org/10.1016/j.freeradbiomed.2022.09.007